Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-16

Clinical Trial Update: Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Metformin in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 trial evaluated whether eslicarbazepine acetate alters the pharmacokinetics of metformin in healthy volunteers; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • eslicarbazepine acetate (eslicarbazepine acetate)
  • metformin (metformin)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Neuropathic Pain | Phase 1 | Status: COMPLETED | Results posted: 2014-12-16